Lee and colleagues demonstrate that AAV2-shmTOR alleviates hypoxia-induced inflammation in retinopathies by downregulating mTOR signaling, reducing CCL3 secretion in Müller cells, and limiting CCR5-positive microglia. The gene discussed is MTOR; the disease is retinal disorder.